Basel Medical Group Ltd Ordinary Shares (BMGL) — Long-term Investment Intensity

Latest as of June 2025: 0.0%

Basel Medical Group Ltd Ordinary Shares (BMGL) has a Long-term Investment Intensity of 0.0% as of June 2025. Long-term investments of $49.00 represent 0.0% of total assets of $16.85 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Basel Medical Group Ltd Ordinary Shares (BMGL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

LT Investment Intensity

0.0%
LT Investments / Total Assets

Long-term Investments

$49.00
USD

Total Assets

$16.85 Million
USD

Country

USA
NASDAQ

Basel Medical Group Ltd Ordinary Shares Long-term Investment Intensity (2025–2025)

This chart shows how Basel Medical Group Ltd Ordinary Shares's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2025, the intensity stands at 0.0%, reflecting long-term investments of $49.00 against total assets of $16.85 Million USD. For the complete balance sheet picture, see BMGL total asset value.

Annual Long-term Investment Intensity for Basel Medical Group Ltd Ordinary Shares (2025–2025)

The table below presents the year-by-year Long-term Investment Intensity for Basel Medical Group Ltd Ordinary Shares from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BMGL total debt and obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 0.0% $49.00 $16.85 Million
pp = percentage points